Finally, we found that the inhibitory effects of InuA on MDM2 and NFAT1 were critical for its anti-prostate cancer activities, as demonstrated using MDM2 and NFAT1 double KD prostate cancer cell lines. This evidence concerns the gene MDM2 and prostate carcinoma.